June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
TNFAIP3 may be key to TLR4-activation of the inflammasome in the retinal vasculature
Author Affiliations & Notes
  • Li Liu
    OVAS, Wayne State University School of Medicine, Detroit, Michigan, United States
  • Youde Jiang
    OVAS, Wayne State University School of Medicine, Detroit, Michigan, United States
  • Jena Jean Steinle
    OVAS, Wayne State University School of Medicine, Detroit, Michigan, United States
  • Footnotes
    Commercial Relationships   Li Liu None; Youde Jiang None; Jena Steinle None
  • Footnotes
    Support  R01EY0228442 (JJS); R01EYR01EY030284 (JJS); P30EY04068 (LDH)
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 276 – F0321. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Li Liu, Youde Jiang, Jena Jean Steinle; TNFAIP3 may be key to TLR4-activation of the inflammasome in the retinal vasculature. Invest. Ophthalmol. Vis. Sci. 2022;63(7):276 – F0321.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To determine whether tumor necrosis factor, alpha-induced protein 3 (TNFAIP3) regulated toll-like receptor 4 (TLR4) actions on the NOD-like receptor protein 3 (NLRP3) inflammasome.

Methods : Western blotting was done on retinal lysates from TLR4 floxed and endothelial cell specific TLR4 knockout mice for TNFAIP3, TLR4, and NLRP3 pathway proteins. Retinal endothelial cells (REC) were grown in normal and high glucose and treated with TNFAIP3 siRNA, followed by Western blotting for TLR4 and NLRP3 pathway proteins.

Results : Loss of TLR4 in endothelial cells increased TNFAIP3 levels, while decreasing NLRP3 pathway proteins. High glucose culturing conditions increased TLR4 and NLRP3 proteins, which were increased by TNFAIP3 siRNA.

Conclusions : Data demonstrate that TLR4 regulates NLRP3 pathway proteins. TNFAIP3 can regulate TLR4 and the NLRP3 pathway. TNFAIP3 may offer a new target for therapeutic development against retinal inflammation

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×